Febuxostat-Induced Toxic Epidermal Necrolysis

Am J Ther. 2022 Nov-Dec;29(6):e710-e712. doi: 10.1097/MJT.0000000000001256. Epub 2020 Oct 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Febuxostat / adverse effects
  • Humans
  • Stevens-Johnson Syndrome* / diagnosis
  • Stevens-Johnson Syndrome* / etiology

Substances

  • Febuxostat